← Back to Search

Happy Lane Hemp Extract/CBD soft gels (25 mg/capsule) for Healthy Subjects

Phase < 1
Waitlist Available
Led By Igor Koturbash, MD, PhD
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 13 days
Awards & highlights

Study Summary

This trial will determine the levels of major cannabinoids and cannabinoid metabolites in the plasma of healthy volunteers following 10 days of supplementation with 25 mg CBD soft gels.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~13 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 13 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Amount of 11-OH-THC in plasma of healthy volunteers that have ingested hemp extract/CBD for 10 consecutive days using LCMS
Amount of CBD in plasma of healthy volunteers that have ingested hemp extract/CBD for 10 consecutive days using LCMS
Amount of CBD-OH in plasma of healthy volunteers that have ingested hemp extract/CBD for 10 consecutive days using LCMS
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: 50 mg/day dose of Happy Lane CBD (Larger Dose)Experimental Treatment1 Intervention
Two 25 mg Happy Lane CBD gel capsules per day (50 mg/day total dose) for 10 consecutive days at approximately the same time of day (±1 hour) on each of these days. Both capsules will be taken at the same time as each other.
Group II: 25 mg/day dose of Happy Lane CBD (Lower Dose)Experimental Treatment1 Intervention
One 25 mg Happy Lane CBD gel capsule per day (25 mg/day total dose) for 10 consecutive days at approximately the same time of day (±1 hour) on each of these days.

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
486 Previous Clinical Trials
150,353 Total Patients Enrolled
Igor Koturbash, MD, PhDPrincipal InvestigatorUniversity of Arkansas

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for participants of this trial?

"Clinicaltrials.gov states that this research initiative, which was initially published on December 1st 2022 and revised most recently in January 10th of the same year, is not accepting applicants currently. However, 839 other trials are actively seeking participants right now."

Answered by AI

Are octogenarians being granted admittance to this experiment?

"The current clinical trial is only open to individuals aged between 18 and 45. By contrast, there are 50 experiments available for minors and 371 studies intended for seniors."

Answered by AI

Are there any criteria that would permit me to partake in this clinical trial?

"This clinical trial seeks 20 participants aged 18 to 45 who self-identify as healthy subjects (HS). Eligible candidates must also attest that they will not use any prescription or OTC drugs and/or supplements during the study period, abstain from using other cannabinoid products for duration of the research, and meet age requirements."

Answered by AI
~0 spots leftby Apr 2025